PyInvesting

Market research

WHA.AU Wattle Health Australia Limited

AU AUD Consumer Defensive

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
109M
P/E ratio
Not available
Analyst target
Not available
Dividend yield
0.0%
Beta
0.65

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Wattle Health Australia Limited is currently in a long term downtrend where the price is trading 4.4% below its 200 day moving average.

From a valuation standpoint, the stock is 1810.0% more expensive than other stocks from the Consumer Defensive sector with a price to sales ratio of 129.7.

Wattle Health Australia Limited's total revenue rose by 38.1% to $714K since the same quarter in the previous year.

Its net income has dropped by 75.7% to $-17M since the same quarter in the previous year.

Finally, its free cash flow grew by 91.2% to $-2M since the same quarter in the previous year.

Based on the above factors, Wattle Health Australia Limited gets an overall score of 2/5.